Navigation Links
Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
Date:7/25/2008

PLEASANTON, Calif., July 25 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR) a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the second quarter and first six months of fiscal 2008 on Thursday, July 31.

The company will hold a conference call to discuss its financial results and operating activities to all interested parties at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Thursday, July 31, hosted by Gary F. Burbach, president and chief executive officer, and David Smith, executive vice president and chief financial officer.

The teleconference can be accessed by calling (913) 312-0379, passcode 4566478. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at http://phx.corporate- ir.net/phoenix.zhtml?p=irol-eventDetails&c=95989&eventID=1890100 or at http://www.thoratec.com

A replay of the conference call will be available through Thursday, August 7, via http://www.thoratec.com or by telephone at (719) 457-0820, passcode 4566478.

Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate (R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com or http://www.itcmed.com


'/>"/>
SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thoratec Schedules First Quarter 2008 Conference Call, Webcast
2. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
3. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
4. Thoratecs ITC Division Receives FDA Warning Letter
5. Thoratec Schedules Third Quarter Conference Call, Webcast
6. AMICAS Schedules Second Quarter Earnings Call
7. Mylan Schedules Financial Results Conference Call and Live Webcast for the Second Quarter Fiscal 2008
8. Gentiva(R) Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday, July 31, 2008
9. Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast
10. Robbins & Myers Schedules Third Quarter Fiscal 2008 Financial Results Conference Call
11. Immucor Schedules Fiscal 2009 Guidance Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Erlanger Agency has announced a new ... area. The latest campaign focuses on the fight against breast cancer, fundraising for a ... accepted here . , Carmen is a loving single mother of two boys ...
(Date:2/12/2016)... San Ramon, CA (PRWEB) , ... February 12, 2016 , ... ... tissue donation in northern California and Nevada, announced a partnership with San Ramon Regional ... be transferred to the hospital’s facilities as a way to accommodate a more certain ...
(Date:2/12/2016)... FL (PRWEB) , ... February 12, 2016 , ... For ... Dental hygienist Suzan Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 a.m. ... joined dozens of dental professionals, donating their time and skills to help hundreds of ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... “Revolutionizing Cancer Care.” , The print component of “Revolutionizing Cancer Care” ... Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation of approximately 250,000 ...
(Date:2/12/2016)... ... 12, 2016 , ... Atlantic Information Services, Inc. (AIS) is ... an upcoming Feb. 24 webinar that will discuss ways health plans and PBMs ... as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors to treat ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Ky. , Feb. 12, 2016 /PRNewswire/ ... has completed a $47.1 million Series D ... Cormorant Asset Management, Hillhouse Capital Group and ... Morningside Venture Investments, AJU IB Investment, and ... be used to further advance clinical trials ...
(Date:2/11/2016)... The primary goal of this research is ... the usage of liquid biopsy. Key information the survey ... Timeframe of liquid biopsy adoption amidst future users - ... type - Sample inflow to conduct liquid biopsy tests ... and so on. - Correlation analysis of sample type ...
(Date:2/11/2016)... Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... improving the lives of pets, today announced the submission ... New Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, ... (KB0120) of Zimeta for the control of pyrexia (fever) ... --> --> The Chemistry, ...
Breaking Medicine Technology: